1st Quarter - Report

AMERICAN ACADEMY OF NEUROLOGY for AMERICAN ACADEMY OF NEUROLOGY

Firm
Client
Income
—
Expenses
$430,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Veterans VET

Strengthening the VA Centers of Excellence

LobbyistCovered position, as disclosed
DEREK CHRISTOPHER BRANDT —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

S. 1391 / H.R. 2296: FAIR Accountability and Innovative Research Drug Pricing Act; all provisions. S. 2387: We Protect American Investment in Drugs (PAID) Act; all provisions. S. 2443: Investment in Tomorrow's Pediatric Health Care Workforce Act; all provisions. S. 2546 / H.R. 2279: Safe Step Act; all provisions. H.R. 1379: the Ensuring Lasting Smiles Act; all provisions. H.R. 2781: Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act, section 4. H.R. 3502: Protecting People from Surprise Medical Bills Act; all provisions. H.R. 6074: Coronavirus Preparedness and Response Supplemental Appropriations Act; all provisions. H.R. 6201: Families First Coronavirus Response Act; all provisions. Supporting policies to address prescription drug costs, including funding for personal protective equipment and expanding telemedicine. Funding for the CDC National Neurological Conditions Surveillance System. Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, AHRQ, and the NIH including the BRAIN Initiative. Funding for Congressionally Directed Medical Research Programs at the DoD. Lifting the federal ban restricting HHS from studying a Universal Patient Identifier. Policy to address surprise medical billing. Promoting interoperability in electronic health records.

LobbyistCovered position, as disclosed
DEREK CHRISTOPHER BRANDT —
MATTHEW ROSS KERSCHNER —
MICHAEL LISOWSKI New Senior Legislative Assistant, Rep. Joe Heck.

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 1379 (116th), S. 2443 (116th), S. 2387 (116th), H.R. 2296 (116th), H.R. 2781 (116th), H.R. 6201 (116th), H.R. 6074 (116th), S. 1391 (116th), H.R. 2279 (116th), H.R. 3502 (116th), S. 2546 (116th)

Medicare/Medicaid MMM

S. 2543: Prescription Drug Pricing Reduction Act; sections 102, 107, 110, 121, 128, 141. H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act; all provisions. H.R. 3107: Improving Seniors' Timely Access to Care Act of 2019; all provisions. Supporting policies to address the COVID-19 pandemic, including expanding telemedicine, support for physician practices, and regulatory relief. Supporting CMSs final rule on Evaluation and Management (E/M) billing codes. Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D. Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability. Improvements to the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015. Medicare coverage of oxygen therapy for cluster headaches. Advocating for reform to stark and anti-kickback laws to promote value-based payment arrangements.

LobbyistCovered position, as disclosed
DEREK CHRISTOPHER BRANDT —
MATTHEW ROSS KERSCHNER —
MICHAEL LISOWSKI New Senior Legislative Assistant, Rep. Joe Heck.

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3 (116th), S. 2543 (116th), H.R. 3107 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.